In the last 12 months, insiders at AETHLON MEDICAL INC ($AEMD) filed 50 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
AETHLON MEDICAL INC operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Shah Chetan (Director) — 13 transactions totaling $71,774
- Gikakis Nicolas (Director) — 11 transactions totaling $68,679
- BROENNIMAN EDWARD G (Director) — 13 transactions totaling $65,678
- Gikakis Nicolas (Not found) — 3 transactions totaling $55,898
- Shah Chetan (Not found) — 3 transactions totaling $53,594
View all SEC Filings for AETHLON MEDICAL INC (AEMD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | BROENNIMAN EDWARD G | Director | F | Common Stock | 89 | $2.19 | 1,915.0000 | 1,315,110 | 4.44% | 0.01% |
| March 31, 2026 | Shah Chetan | Director | F | Common Stock | 178 | $2.19 | 1,463.0000 | 1,315,110 | 10.85% | 0.01% |
| March 31, 2026 | Gikakis Nicolas | Director | F | Common Stock | 178 | $2.19 | 1,464.0000 | 1,315,110 | 10.84% | 0.01% |
| Dec. 31, 2025 | Shah Chetan | Director | F | Common Stock | 179 | $2.77 | 2,356.0000 | 761,318 | 7.06% | 0.02% |
| Dec. 31, 2025 | BROENNIMAN EDWARD G | Director | F | Common Stock | 89 | $2.77 | 2,807.0000 | 761,318 | 3.07% | 0.01% |
| Dec. 31, 2025 | Gikakis Nicolas | Director | F | Common Stock | 179 | $2.77 | 2,357.0000 | 761,318 | 7.06% | 0.02% |
| Sept. 30, 2025 | Shah Chetan | Director | F | Common Stock | 1786 | $0.75 | 22,672.0000 | 2,585,316 | 7.30% | 0.07% |
| Sept. 30, 2025 | Gikakis Nicolas | Director | F | Common Stock | 1786 | $0.75 | 22,683.0000 | 2,585,316 | 7.30% | 0.07% |
| Sept. 30, 2025 | BROENNIMAN EDWARD G | Director | F | Common Stock | 893 | $0.75 | 25,397.0000 | 2,585,316 | 3.40% | 0.03% |
| June 30, 2025 | BROENNIMAN EDWARD G | Director | F | Common Stock | 893 | $1.20 | 21,825.0000 | 2,585,316 | 3.93% | 0.03% |
| June 30, 2025 | Shah Chetan | Director | F | Common Stock | 1786 | $1.20 | 19,993.0000 | 2,585,316 | 8.20% | 0.07% |
| June 30, 2025 | Gikakis Nicolas | Director | F | Common Stock | 1786 | $1.20 | 20,004.0000 | 2,585,316 | 8.20% | 0.07% |
| April 23, 2025 | Shah Chetan | Director | A | Common Stock | 142857 | $0.36 | 174,233.0000 | 0 | 45.05% | 0.00% |
| April 23, 2025 | Gikakis Nicolas | Director | A | Common Stock | 142857 | $0.35 | 174,320.0000 | 0 | 454.05% | 0.00% |
| April 23, 2025 | Rossetti Angela | Director | A | Common Stock | 142857 | $0.35 | 343,400.0000 | 0 | 71.24% | 0.00% |
| April 23, 2025 | BROENNIMAN EDWARD G | Director | A | Common Stock | 142857 | $0.35 | 181,741.0000 | 0 | 367.39% | 0.00% |
| March 31, 2025 | BROENNIMAN EDWARD G | Director | F | Common Stock | 1645 | $0.36 | 38,884.0000 | 0 | 4.06% | 0.00% |
| March 31, 2025 | Shah Chetan | Director | F | Common Stock | 3289 | $0.36 | 31,376.0000 | 0 | 9.49% | 0.00% |
| March 31, 2025 | Gikakis Nicolas | Director | F | Common Stock | 3289 | $0.36 | 31,463.0000 | 0 | 9.46% | 0.00% |
| Dec. 31, 2024 | Gikakis Nicolas | Director | F | Common Stock | 3289 | $0.86 | 34,752.0000 | 0 | 8.65% | 0.00% |
| Dec. 31, 2024 | Shah Chetan | Director | F | Common Stock | 3289 | $0.86 | 34,665.0000 | 0 | 8.67% | 0.00% |
| Dec. 31, 2024 | BROENNIMAN EDWARD G | Director | F | Common Stock | 1645 | $0.86 | 40,529.0000 | 0 | 3.90% | 0.00% |
| Sept. 30, 2024 | Shah Chetan | Director | F | Common Stock | 3289 | $0.47 | 37,954.0000 | 0 | 7.97% | 0.00% |
| Sept. 30, 2024 | Gikakis Nicolas | Director | F | Common Stock | 3289 | $0.47 | 38,041.0000 | 0 | 7.96% | 0.00% |
| Sept. 30, 2024 | BROENNIMAN EDWARD G | Director | F | Common Stock | 1645 | $0.47 | 42,174.0000 | 0 | 3.75% | 0.00% |
| June 28, 2024 | Shah Chetan | Not found | F | Common Stock | 3289 | $0.50 | 41,243.0000 | 0 | 7.39% | 0.00% |
| June 28, 2024 | BROENNIMAN EDWARD G | Not found | F | Common Stock | 1645 | $0.50 | 43,819.0000 | 0 | 3.62% | 0.00% |
| June 28, 2024 | Gikakis Nicolas | Not found | F | Common Stock | 5244 | $0.50 | 41,330.0000 | 0 | 11.26% | 0.00% |
| April 16, 2024 | BROENNIMAN EDWARD G | Not found | A | Common Stock | 32894 | $1.52 | 45,464.0000 | 0 | 261.69% | 0.00% |
| April 16, 2024 | Rossetti Angela | Not found | A | Common Stock | 32894 | $1.52 | 200,543.0000 | 0 | 19.62% | 0.00% |
| April 16, 2024 | Shah Chetan | Not found | A | Common Stock | 32894 | $1.52 | 44,532.0000 | 0 | 282.64% | 0.00% |
| April 16, 2024 | Gikakis Nicolas | Not found | A | Common Stock | 32894 | $1.52 | 46,574.0000 | 0 | 240.45% | 0.00% |
| March 29, 2024 | Gikakis Nicolas | Not found | F | Common Stock | 1954 | $1.68 | 13,680.0000 | 0 | 12.50% | 0.00% |
| March 29, 2024 | BROENNIMAN EDWARD G | Not found | F | Common Stock | 1163 | $1.68 | 12,570.0000 | 0 | 8.47% | 0.00% |
| March 29, 2024 | Shah Chetan | Not found | F | Common Stock | 1163 | $1.68 | 11,638.0000 | 0 | 9.09% | 0.00% |
| Dec. 29, 2023 | Gikakis Nicolas | Director | F | Common Stock | 1954 | $2.19 | 15,634.0000 | 0 | 11.11% | 0.00% |
| Dec. 29, 2023 | BROENNIMAN EDWARD G | Director | F | Common Stock | 1163 | $2.19 | 13,733.0000 | 0 | 7.81% | 0.00% |
| Dec. 29, 2023 | Shah Chetan | Director | F | Common Stock | 1163 | $2.19 | 12,801.0000 | 0 | 8.33% | 0.00% |
| Sept. 29, 2023 | Shah Chetan | Director | F | Common Stock | 11628 | $0.23 | 139,637.0000 | 0 | 7.69% | 0.00% |
| Sept. 29, 2023 | BROENNIMAN EDWARD G | Director | F | Common Stock | 11628 | $0.23 | 148,957.0000 | 0 | 7.24% | 0.00% |
| Sept. 29, 2023 | Gikakis Nicolas | Director | F | Common Stock | 19541 | $0.23 | 175,873.0000 | 0 | 10.00% | 0.00% |
| July 3, 2023 | Gikakis Nicolas | Director | A | Common Stock | 195414 | $0.00 | 195,414.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | BROENNIMAN EDWARD G | Director | F | Common Stock | 11628 | $0.36 | 160,585.0000 | 0 | 6.75% | 0.00% |
| June 30, 2023 | Shah Chetan | Director | F | Common Stock | 11628 | $0.36 | 151,265.0000 | 0 | 7.14% | 0.00% |
| April 28, 2023 | Rossetti Angela | Director | A | Common Stock | 116279 | $0.00 | 167,649.0000 | 0 | 226.36% | 0.00% |
| April 28, 2023 | Shah Chetan | Director | A | Common Stock | 116279 | $0.00 | 162,893.0000 | 0 | 249.45% | 0.00% |
| April 28, 2023 | BROENNIMAN EDWARD G | Director | A | Common Stock | 116279 | $0.00 | 172,213.0000 | 0 | 207.89% | 0.00% |
| March 31, 2023 | Shah Chetan | Director | F | Common Stock | 3425 | $0.39 | 46,614.0000 | 0 | 6.84% | 0.00% |
| March 31, 2023 | BROENNIMAN EDWARD G | Director | F | Common Stock | 3425 | $0.39 | 55,934.0000 | 0 | 5.77% | 0.00% |
| Feb. 1, 2023 | Arnold Lee D | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 60620 | $0.00 | 60,620.0000 | 0 | 9999.99% | 0.00% |